Ipilimumab vs Pregabalin
Ipilimumab vs Pregabalin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Pregabalin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pregabalin: Binds alpha-2-delta subunit of voltage-gated calcium channels.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Pregabalin β 6.3 hours.
Chemical Properties
Molecular Formula: Pregabalin β C8H17NO2.
Molecular Weight: Pregabalin β 159.2260 g/mol.
Type: Ipilimumab β Antibody; Pregabalin β Small molecule.